Skip to content
Standard of Care Regulation Continuing Education for Pharmacy Professionals
This 1-hour, knowledge-based webinar examines how standard of care regulatory models are influencing contemporary pharmacy practice. Participants will compare bright-line regulation and standard of care regulation while exploring how these approaches affect pharmacist and pharmacy technician scope of practice, professional accountability, and patient-centered care.
The webinar reviews the principles of standard of care regulation, the role of professional judgment in pharmacy practice, and examples of evolving regulatory models from across the United States. Participants will also examine how regulatory flexibility can support innovation while maintaining patient safety and accountability.
Topics include:
- Differences between bright-line and standard of care regulatory models
- Professional judgment and accountability in pharmacy practice
- The impact of regulatory approaches on pharmacist and pharmacy technician scope of practice
- Patient-centered care and access to healthcare services
- State examples illustrating evolving pharmacy regulatory models
Q: Who should attend this webinar?
Pharmacists, pharmacy technicians, pharmacy managers, regulatory professionals, and healthcare professionals interested in pharmacy law, regulatory models, and the future of pharmacy practice.
Q: Will I earn CE credit?
Yes. This activity provides 1 contact hour (0.1 CEU) of ACPE-accredited continuing education for pharmacists and pharmacy technicians.
Explore how standard of care regulation is influencing pharmacy practice, professional judgment, and patient-centered care.
REGISTER HERE!
Note: It is not necessary to create a Lecture Panda account to register for this webinar.
The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this knowledge-based program for 1 contact hour (0.1 CEU) of continuing education credit for pharmacists and pharmacy technicians.
Register of Historic Places and is world-famous for its five resident Mallard ducks, who march daily through the lobby at 11am and 5pm.
Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA is a pharmacist-attorney in Frier Levitt’s Life Sciences Department. She is also a registered patent attorney and leads the firm’s Intellectual property team. She has broad and in-depth healthcare and regulatory experience. Her practice focuses on intellectual property (patents, trademarks, copyrights, trade secrets) and healthcare law, Food, Drug, Device & Cosmetic law (all facets-483s to clinical trials to registrations and product approval), pharmacy law and regulatory issues, 503A/503B compounding, Board of Pharmacy (licensing and disciplinary matters), PBM audits, and DSCSA supply chain compliance. Dr. Rumore has over 25 years of health-system, pharmaceutical industry, and law firm experience in the area of Food, Drug & Cosmetic Law, and pharmaceutical intellectual property Dr. Rumore is fluent in cGMPs, GCPs, writing and reviewing Clinical Trial Agreements (CTAs), Investigator brochures, manuscripts, labeling & advertising review, NDAs, study reports, and documents for regulatory submissions. She often prepares legal memoranda on healthcare/FDA matters and conducts Mock State Board of Pharmacy and FDA inspections for compounding pharmacies. Dr. Rumore has practiced both pharmacy and law. She has actual experience as a compounding pharmacist. She regularly counsels on Section 503A and state-specific compounding requirements, assesses compounding practices for state and federal regulatory compliance, including USP 797/795/800, medical necessity documentation, advertising & promotion, reimbursement issues, infrastructure, and preparing compounding policies and procedures that provide clear guidelines, standards, and training for staff. Previously, she was at the Director level in Drug Regulatory Affairs/Compliance in the pharmaceutical industry and hospital pharmacy. She taught Pharmacy Law, Drug Regulatory Affairs, and Food Drug & Cosmetic Law at several New York Colleges of Pharmacy and currently teaches Food, Drug & Cosmetic Law at Maurice A. Deane School of Law at Hofstra University. She is a frequent lecturer and has over 200 publications and presentations.
